Thinking about getting a spring-time booster shot? A new study coming out of York ... Immunity Task-Force project for more ...
Vaccine availability is on a first-come, first-served basis and while supplies last. Updated bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines and boosters will be available at the clinics. The ...
People who got the COVID-19 booster had stronger protection against the virus that causes the disease compared to people who ...
Pfizer-BioNTech, Moderna, Sanofi/GSK and Novavax. Those getting the spring booster will be given an mRNA vaccine made by either Pfizer or Moderna. Both have been updated to help protect against ...
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
US firm Moderna is suing American competitor Pfizer and its German-partner BioNTech for alleged patent infringement in relation to their Comirnaty vaccine, arguing it is due compensation for ...
But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid". The hearing is due to start at the High Court in London from 0930 GMT and is expected to last until ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna ...